Observations placeholder
Navelbine
Identifier
019676
Type of Spiritual Experience
Background
A description of the experience
Vinorelbine (NVB), sold under the trade name Navelbine, is a chemotherapy medication that is used to treatment a number of types of cancer, including breast cancer and non-small cell lung cancer
Side effects
Vinorelbine has a number of side-effects that can limit its use:
Chemotherapy-induced peripheral neuropathy (a progressive, enduring and often irreversible tingling numbness, intense pain, and hypersensitivity to cold, beginning in the hands and feet and sometimes involving the arms and leg, lowered resistance to infection, bruising or bleeding, anaemia, constipation, diarrhea, nausea, tiredness and a general feeling of weakness (asthenia), inflammation of the vein into which it was injected (phlebitis). Seldom severe hyponatremia is seen.
Less common effects are hair loss and allergic reaction.
On Jan, 8, 2016: 6,021 people reported to have side effects when taking Navelbine. Among them, 27 people (0.45%) have Hallucination.
Time on Navelbine when people have Hallucination :
| n/a |
Gender of people who have Hallucination when taking Navelbine :
| Female | Male | |
| Hallucination | 77.78% | 22.22% |
Age of people who have Hallucination when taking Navelbine :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 0.00% | 0.00% | 4.76% | 0.00% | 9.52% | 85.71% |
On Jan, 21, 2016: 6,021 people reported to have side effects when taking Navelbine. Among them, 223 people (3.70%) have Death.
Time on Navelbine when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 44.68% | 42.55% | 12.77% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Death when taking Navelbine :
| Female | Male | |
| Death | 67.56% | 32.44% |
Age of people who have Death when taking Navelbine :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 0.00% | 0.54% | 0.00% | 10.75% | 23.66% | 65.05% |
Top conditions involved for these people :
- Breast cancer (73 people, 32.74%)
- Metastases to bone (44 people, 19.73%)
- Breast cancer metastatic (24 people, 10.76%)
- Anaemia (18 people, 8.07%)
- Non-small cell lung cancer (14 people, 6.28%)